A rapid global review of strategies to improve influenza vaccination uptake in Australia.
Hassen Mohammed, Mark McMillan, Prabha H Andraweera, Salenna R Elliott, Helen S Marshall
Author Information
Hassen Mohammed: Vaccinology and Immunology Research Trials Unit, Women's and Children's Health Network, Adelaide, Australia. ORCID
Mark McMillan: Vaccinology and Immunology Research Trials Unit, Women's and Children's Health Network, Adelaide, Australia. ORCID
Prabha H Andraweera: Vaccinology and Immunology Research Trials Unit, Women's and Children's Health Network, Adelaide, Australia. ORCID
Salenna R Elliott: Vaccinology and Immunology Research Trials Unit, Women's and Children's Health Network, Adelaide, Australia.
Helen S Marshall: Vaccinology and Immunology Research Trials Unit, Women's and Children's Health Network, Adelaide, Australia. ORCID
中文译文
English
This study aimed to identify effective strategies for improving the uptake of influenza vaccination and to inform recommendations for influenza vaccination programs in Australia. A rapid systematic review was conducted to assimilate and synthesize peer-reviewed articles identified in PubMed. The National Health and Medical Research Council (NHMRC) Hierarchy of Evidence was used to appraise the quality of evidence. A systematic search identified 4373 articles and 52 that met the inclusion criteria were included. The evidence suggests influenza vaccination uptake may be improved by interventions that (1) increase community/patient demand and access to influenza vaccine and overcome practice-related barriers; (2) reinforce the critical role healthcare providers play in driving influenza vaccination uptake. Strategies such as standing orders, reminder and recall efforts were successful in improving influenza vaccination rates. Community pharmacies, particularly in regional/remote areas, are well positioned to improve influenza vaccine coverage. The findings of this rapid review can be utilized to improve the performance of influenza immunization programs in Australia and other countries with comparable programs; and recommend priorities for future evaluation of interventions to improve influenza vaccination uptake.
Fam Pract. 2021 Jul 28;38(4):524-536
[PMID: 33517381 ]
Vaccine. 2019 Aug 23;37(36):5257-5264
[PMID: 31353257 ]
Am J Prev Med. 2014 Jan;46(1):1-9
[PMID: 24355665 ]
BMC Med Res Methodol. 2009 Jun 11;9:34
[PMID: 19519887 ]
JAMA. 2012 Apr 25;307(16):1702-8
[PMID: 22535855 ]
Clin Pediatr (Phila). 2019 Apr;58(4):428-436
[PMID: 30600690 ]
Vaccine. 2020 Aug 27;38(38):5966-5978
[PMID: 32620374 ]
J Gen Intern Med. 2018 May;33(5):659-667
[PMID: 29383550 ]
Proc Natl Acad Sci U S A. 2021 May 18;118(20):
[PMID: 33926993 ]
Vaccine. 2020 Apr 16;38(18):3508-3514
[PMID: 31787410 ]
Iran J Public Health. 2020 Dec;49(12):2256-2263
[PMID: 34178732 ]
Am J Prev Med. 2015 Oct;49(4):563-72
[PMID: 26232904 ]
Ann Fam Med. 2017 Nov;15(6):507-514
[PMID: 29133488 ]
Am J Public Health. 2014 Feb;104 Suppl 1:e7-12
[PMID: 24354839 ]
Vaccine. 2021 Jan 22;39(4):658-666
[PMID: 33357955 ]
J Glob Health. 2020 Dec;10(2):021102
[PMID: 33312512 ]
Intern Emerg Med. 2018 Aug;13(5):673-678
[PMID: 29797288 ]
Am J Public Health. 2019 Dec;109(12):1776-1783
[PMID: 31622142 ]
Pediatr Emerg Care. 2020 Nov;36(11):e641-e645
[PMID: 31913247 ]
Pediatrics. 2021 Mar;147(3):
[PMID: 33558309 ]
J Gen Intern Med. 2017 Jul;32(7):790-795
[PMID: 28337690 ]
Medwave. 2020 Jul 15;20(6):e7963
[PMID: 32678814 ]
Res Social Adm Pharm. 2021 Jan;17(1):2040-2041
[PMID: 32921570 ]
Res Social Adm Pharm. 2020 Apr;16(4):497-502
[PMID: 31262643 ]
Pediatrics. 2019 Aug;144(2):
[PMID: 31292219 ]
BMC Public Health. 2018 Jun 26;18(1):787
[PMID: 29940903 ]
J Adv Nurs. 2017 Mar;73(3):742-752
[PMID: 27943377 ]
Hum Vaccin Immunother. 2020 Nov 1;16(11):2809-2815
[PMID: 32238041 ]
J Am Pharm Assoc (2003). 2018 Sep - Oct;58(5):505-514.e2
[PMID: 30076098 ]
Vaccine. 2015 Feb 4;33(6):759-70
[PMID: 25556592 ]
PLoS One. 2018 Feb 9;13(2):e0192155
[PMID: 29425226 ]
Vaccine. 2016 Oct 26;34(45):5400-5405
[PMID: 27646030 ]
Vaccine. 2017 Feb 1;35(5):842-848
[PMID: 28062124 ]
Hum Vaccin Immunother. 2016 May 3;12(5):1225-8
[PMID: 26863888 ]
Vaccine. 2020 Feb 5;38(6):1370-1377
[PMID: 31862197 ]
Vaccine. 2016 Nov 11;34(47):5708-5723
[PMID: 27765379 ]
Am J Prev Med. 2019 Oct;57(4):e125-e133
[PMID: 31471001 ]
Am J Prev Med. 2012 Jan;42(1):71-5
[PMID: 22176850 ]
Cochrane Database Syst Rev. 2018 May 30;5:CD005188
[PMID: 29845606 ]
Dtsch Arztebl Int. 2019 Sep 27;116(39):645-652
[PMID: 31617479 ]
J Pediatr Health Care. 2013 Sep-Oct;27(5):327-33
[PMID: 22321581 ]
BMJ Open. 2016 Feb 19;6(2):e010069
[PMID: 26895984 ]
Vaccine. 2018 Sep 5;36(37):5524-5535
[PMID: 30078745 ]
J Med Internet Res. 2020 Sep 25;22(9):e16373
[PMID: 32975529 ]
Cochrane Database Syst Rev. 2018 Jan 18;1:CD003941
[PMID: 29342498 ]
BMJ Open. 2016 Sep 20;6(9):e011948
[PMID: 27650763 ]
Aust N Z J Public Health. 2018 Oct;42(5):447-450
[PMID: 30035839 ]
Vaccine. 2018 Oct 29;36(45):6790-6795
[PMID: 30279091 ]
Vaccine. 2018 May 11;36(20):2751-2759
[PMID: 29661584 ]
Appl Clin Inform. 2019 Oct;10(5):944-951
[PMID: 31860114 ]
Am J Prev Med. 2018 Aug;55(2):231-239
[PMID: 29910118 ]
BMJ Open. 2016 Feb 16;6(2):e009739
[PMID: 26883237 ]
Vaccine. 2016 Jan 2;34(1):20-32
[PMID: 26602267 ]
Australia
Humans
Immunization Programs
Influenza Vaccines
Influenza, Human
Pharmacies
Vaccination